Interview with Prof. Jonathan Kimmelman by Second Opinion published on 2017-02-01T21:35:33Z Second Opinion speaks with Prof. Jonathan Kimmelman, whose commentary about raising the bar for approving first-in-human clinical trials appeared in the journal Nature this week. Link to Prof. Kimmelman's commentary: http://www.nature.com/news/consider-drug-efficacy-before-first-in-human-trials-1.21384 Genre Science
